Talphera (TLPH) Market Capitalization (2011 - 2026)
Talphera (TLPH) posted Market Capitalization of $77.8 million for Q2 2026, up 48.56% on a QoQ basis from $52.4 million in Q1 2026, and up 389.76% year-over-year from $15.9 million in Q2 2025.
Analysis
Talphera (TLPH) Market Capitalization (2011 - 2026) Analysis & Trends
Talphera has reported Market Capitalization for 16 years, with the latest figure at $77.8 million in Q2 2026.
- On a quarterly basis, Market Capitalization rose 389.76% year-over-year to $77.8 million in Q2 2026; TTM through Jun 2026 was $77.8 million, a 389.76% increase from a year earlier, with the FY2025 full-year figure at $56.2 million, up 318.42% from the prior year.
- Market Capitalization was $77.8 million for Q2 2026 at Talphera, up from $52.4 million in the prior quarter.
- The five-year high for Market Capitalization was $77.8 million in Q2 2026, with the low at $7.2 million in Q1 2023.
- Average Market Capitalization over 5 years is $28.3 million, with a median of $22.9 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Market Capitalization plunged 83.1% in 2023, then soared 389.76% in 2026.
- Over 5 years, Market Capitalization stood at $18.6 million in 2022, then plunged by 32.67% to $12.5 million in 2023, then climbed by 7.14% to $13.4 million in 2024, then soared by 318.42% to $56.2 million in 2025, then surged by 38.34% to $77.8 million in 2026.
- The last three Market Capitalization figures came in at $77.8 million (Q2 2026), $52.4 million (Q1 2026), and $56.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.79 Mn |
| Mar 31, 2026 | 52.37 Mn |
| Dec 31, 2025 | 56.23 Mn |
| Sep 30, 2025 | 40.57 Mn |
| Jun 30, 2025 | 15.88 Mn |
| Mar 31, 2025 | 13.13 Mn |
| Dec 31, 2024 | 13.44 Mn |
| Sep 30, 2024 | 22.54 Mn |
| Jun 30, 2024 | 23.32 Mn |
| Mar 31, 2024 | 25.46 Mn |
| Dec 31, 2023 | 12.54 Mn |
| Sep 30, 2023 | 9.83 Mn |
| Jun 30, 2023 | 12.20 Mn |
| Mar 31, 2023 | 7.21 Mn |
| Dec 31, 2022 | 18.63 Mn |
| Sep 30, 2022 | 31.11 Mn |
| Jun 30, 2022 | 35.36 Mn |
| Mar 31, 2022 | 42.66 Mn |
| Dec 31, 2021 | 76.62 Mn |
| Sep 30, 2021 | 121.70 Mn |